← Back
$APGE All transactions

Apogee Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$14K

Shares

200

Price

$69

Filed

Feb 4

Insider

Name

Dambkowski Carl

Title

Chief Medical Officer

CIK

0001983476

Roles

Officer

Transaction Details

Transaction Date

2026-02-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

211,148

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 22, 2025. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.24 to $65.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.27 to $66.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.37 to $67.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.80 to $67.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.90 to $68.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | This option represents the right to purchase 175,345 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments through December 18, 2027, subject to the Reporting Person's continued service to the Issuer.

Filing Info

Accession No.

0001104659-26-010454

Form Type

4

Issuer CIK

0001974640

Dambkowski Carl's History

Date Ticker Type Value
2026-04-01 APGE M $94K
2026-04-01 APGE $227K
2026-04-01 APGE $231K
2026-04-01 APGE $9K
2026-04-01 APGE M $0
2026-02-04 APGE M $94K
2026-02-04 APGE $161K
2026-02-04 APGE $93K
2026-02-04 APGE $87K
2026-02-04 APGE $7K

Other Insiders at APGE (90d)

Insider Bought Sold Last
Henderson Jane
Chief Financial Officer
$652K 2026-04-16
HENDERSON MICHAEL THOMAS
Chief Executive Officer
$2.9M 2026-04-16
Dambkowski Carl
Chief Medical Officer
$815K 2026-04-01